Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Canaan (CAN) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for Canaan (CAN) over the last 8 years, with Q3 2025 value amounting to $119.2 billion.

  • Canaan's Cash & Equivalents rose 12387612.16% to $119.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $119.2 billion, marking a year-over-year increase of 12387612.16%. This contributed to the annual value of $96.5 million for FY2024, which is 34.74% up from last year.
  • Canaan's Cash & Equivalents amounted to $119.2 billion in Q3 2025, which was up 12387612.16% from $65.9 million recorded in Q2 2025.
  • In the past 5 years, Canaan's Cash & Equivalents ranged from a high of $119.2 billion in Q3 2025 and a low of $54739.0 during Q1 2024
  • In the last 5 years, Canaan's Cash & Equivalents had a median value of $101.6 million in 2023 and averaged $7.3 billion.
  • In the last 5 years, Canaan's Cash & Equivalents tumbled by 9999.73% in 2023 and then surged by 12387612.16% in 2025.
  • Quarter analysis of 5 years shows Canaan's Cash & Equivalents stood at $427.3 million in 2021, then crashed by 76.73% to $99.4 million in 2022, then dropped by 3.31% to $96.2 million in 2023, then grew by 0.35% to $96.5 million in 2024, then skyrocketed by 123446.97% to $119.2 billion in 2025.
  • Its Cash & Equivalents was $119.2 billion in Q3 2025, compared to $65.9 million in Q2 2025 and $96.5 million in Q4 2024.